Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

BHEL receives LOI for Rs 10,00...
Gujarat Themis Q1 PAT falls ov...
Power Grid Q1 PAT rises 3% YoY...
IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...

Kabra Drugs Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

22 Jul 2024 | 12:00 AM

8.30

0.00 (0.00%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

54.56%

Return (1Y)

Beaten BSE Sensex by 32.64%
More Volatile

3.84%

Standard Deviation (1Y)

Higher than BSE Sensex by 3.03%
Consistent Performer

8/12

Months

beaten BSE Sensex
AxisDirect View

No View

52 Week High-Low

News & Announcements

Kabra Drugs to conduct board meeting
18 days ago

Kabra Drugs to conduct board meeting

09 - Jul - 2024 12:00 AM | 18 days ago

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 12 July 2024.
Powered by Capital Market - Live News
Kabra Drugs reports standalone net loss of Rs 0.37 crore in the March 2024 quarter
57 days ago

Kabra Drugs reports standalone net loss of Rs 0.37 crore in the March 2024 quarter

31 - May - 2024 12:00 AM | 57 days ago

Net Loss of Kabra Drugs reported to Rs 0.37 crore in the quarter ended March 2024 as against net loss of Rs 0.14 crore during the previous quarter ended March 2023. There were no Sales reported in the quarter ended March 2024 and during the previous quarter ended March 2023.
For the full year,net loss reported to Rs 0.74 crore in the year ended March 2024 as against net loss of Rs 0.34 crore during the previous year ended March 2023. There were no Sales reported in the year ended March 2024 and during the previous year ended March 2023.
Powered by Capital Market - Live News
Kabra Drugs announces board meeting date
62 days ago

Kabra Drugs announces board meeting date

25 - May - 2024 12:00 AM | 62 days ago

Kabra Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024.
Powered by Capital Market - Live News
Kabra Drugs reports standalone net loss of Rs 0.11 crore in the December 2023 quarter
163 days ago

Kabra Drugs reports standalone net loss of Rs 0.11 crore in the December 2023 quarter

14 - Feb - 2024 12:00 AM | 163 days ago

Net Loss of Kabra Drugs reported to Rs 0.11 crore in the quarter ended December 2023 as against net loss of Rs 0.06 crore during the previous quarter ended December 2022. There were no Sales reported in the quarter ended December 2023 and during the previous quarter ended December 2022.
Powered by Capital Market - Live News

Price vs Volume

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

General Notifications

My Notifications

Research Notifications

Kabra Drugs Ltd Share Price – BSE Pharmaceuticals, Small Cap

8.30 0.00 (0.00%)

News & Announcements

Price vs Volume

Kabra Drugs Ltd Share Price – BSE
Pharmaceuticals, Small Cap

8.30

0.00 (0.00%)